Clinical aspects of obesity in childhood and adolescence
- 1 February 2001
- journal article
- review article
- Published by Wiley in Obesity Reviews
- Vol. 2 (1) , 29-36
- https://doi.org/10.1046/j.1467-789x.2001.00017.x
Abstract
The level of fatness of a child at which morbidity acutely and/or later in life increases is determined on an acturial basis. Direct measurements of body fat content, e.g. hydrodensitometry, bioimpedance, or DEXA, are useful tools in scientific studies. However, body mass index (BMI) is easy to calculate and is generally accepted now to be used to define obesity in children and adolescents clinically. An increased risk of death from cardiovascular disease in adults has been found in subjects whose BMI had been greater than the 75th percentile as adolescents. Childhood obesity seems to substantially increase the risk of subsequent morbidity whether or not obesity persists into adulthood. The genetic basis of childhood obesity has been elucidated to some extent through the discovery of leptin, the ob gene product, and the increasing knowledge on the role of neuropeptides such as POMC, neuropeptide Y (NPY) and the melanocyte concentrating hormone receptors (for example, MC4R). Environmental/exogenous factors largely contribute to the development of a high degree of body fatness early in life. Twin studies suggest that approximately 50% of the tendency toward obesity is inherited. There are numerous disorders including a number of endocrine disorders (Cushing's syndrome, hypothyroidism, etc.) and genetic syndromes (Prader‐Labhard–Willi syndrome, Bardet Biedl syndrome, etc.) that can present with obesity. A simple diagnostic algorithm allows for the differentiation between primary or secondary obesity. Among the most common sequelae of primary childhood obesity are hypertension, dyslipidemia, back pain and psychosocial problems. Therapeutic strategies include psychological and family therapy, lifestyle/behaviour modification and nutrition education. The role of regular exercise and exercise programmes is emphasized. Surgical procedures and drugs used in adult obesity are still not generally recommended in children and adolescents with obesity. As obesity is the most common chronic disorder in industrialized societies, its impact on individual lives as well as on health economics has to be recognized more widely. This review is aimed towards defining the clinical problem of childhood obesity on the basis of current knowledge and towards outlining future research areas in the field of energy homoeostasis and food intake in relation to child health. Finally, one should aim to increase public awareness of the ever increasing health burden and economic dimension of the childhood obesity epidemic that is present around the globe.Keywords
This publication has 41 references indexed in Scilit:
- Body-Mass Index and Mortality in a Prospective Cohort of U.S. AdultsNew England Journal of Medicine, 1999
- The Role of Leptin in Human PhysiologyNew England Journal of Medicine, 1999
- Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin DeficiencyNew England Journal of Medicine, 1999
- Metabolic Abnormalities and the Role of Leptin in Human ObesityJournal of Clinical Endocrinology & Metabolism, 1999
- Drug Therapy for Obesity--A Therapeutic Option?Journal of Clinical Endocrinology & Metabolism, 1999
- Overweight Is Risking FateJournal of Clinical Endocrinology & Metabolism, 1999
- A leptin missense mutation associated with hypogonadism and morbid obesityNature Genetics, 1998
- Letter from the editorsJournal of Pediatric Endocrinology and Metabolism, 1998
- Leptin as a Metabolic Regulator During Fetal and Neonatal Life and in Childhood and AdolescenceJournal of Pediatric Endocrinology and Metabolism, 1998
- Leptin: The Voice of the Adipose TissueHormone Research, 1997